Therapeutics testing in murine models of fungal infections- aspergillosis, candidiasis, mucormycosis.

Ended Awarded Last action

Contract number
HHSN27200005
Awardee
Awarding agency
Obligated
$1,184,760

Award facts

Contract value 63% obligated
  • $1,184,760.25 Current, with exercised options
  • $1,872,050.25 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
San Antonio, TX 78229, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 5 · Purpose: to DE-obligate excess funds in the amount of $5,462.75 and administratively close out the task order. -$5,463
Other Administrative Action 4 · Purpose: beginning with the effective date of this modification, the government and the contractor mutually agree to extend the expiration date of the base task… $0
Other Administrative Action 3 · Purpose: beginning with the effective date of this modification, article g.1. Is amended to remove rory duncan, PH.d. As the contracting officer's… $0
Other Administrative Action 2 · Purpose: beginning with the effective date of this modification, the expiration date for quantity option 1A and quantity option 1B is extended, at no additional… $0
Exercise an Option 1 $367,962
Original award $822,261

About this award

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to The University of Texas Health Science Center at San Antonio (UTHSCSA). The $1,872,050.25 contract is for THERAPEUTICS TESTING IN MURINE MODELS OF FUNGAL INFECTIONS such as aspergillosis, candidiasis, and mucormycosis. This contract is a delivery order issued under NIAID's larger "Animal Models of Infectious Diseases 2010-2017" indefinite delivery vehicle, a 7-year contract worth up to $146.3 million. There is no set-aside designation for this award. UTHSCSA, a state-controlled institution of higher education that serves as a major hub for clinical and translational research, is the prime contractor. This award contributes to NIAID's mission to develop medical countermeasures against a range of pathogens and supports the agency's pandemic preparedness initiatives by providing specialized modeling and testing services.

Quick answers

Who was awarded contract HHSN27200005?

HHSN27200005 was awarded to The University Of Texas Health Science Center At San Antonio by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 25, 2016.

How much is contract HHSN27200005 worth?

The government has obligated $1,184,760 on HHSN27200005. Its potential value, with all options, is $1,872,050.

Is contract HHSN27200005 an order under another contract?

Yes. HHSN27200005 is a delivery order under HHSN272201000038I, an indefinite delivery contract, on NIAID Animal Models of Infectious Diseases 2010-2017.

Was contract HHSN27200005 competed?

The extent of competition for HHSN27200005 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award